HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

The effect of thyroid hormone and a long-acting somatostatin analogue on TtT-97 murine thyrotropic tumors.

Abstract
Thyroid hormone inhibits thyrotropin (TSH) production and thyrotrope growth. Somatostatin has been implicated as a synergistic factor in the inhibition of thyrotrope function. We have previously shown that pharmacological doses of thyroid hormone (levothyroxine [LT4]) inhibit growth of murine TtT-97 thyrotropic tumors in association with upregulation of somatostatin receptor type 5 (sst5) mRNA and somatostatin receptor binding. In the current study, we examined the effect of physiological thyroid hormone replacement alone or in combination with the long-acting somatostatin analogue, Sandostatin LAR, on thyrotropic tumor growth, thyrotropin growth factor-beta (TSH-beta), and sst5 mRNA expression, as well as somatostatin receptor binding sites. Physiological LT4 replacement therapy resulted in tumor shrinkage in association with increased sst5 mRNA levels, reduced TSH-beta mRNA levels and enhanced somatostatin receptor binding. Sandostatin LAR alone had no effect on any parameter measured. However, Sandostatin LAR combined with LT4 synergistically inhibited TSH-beta mRNA production and reduced final tumor weights to a greater degree. In this paradigm, Sandostatin LAR required a euthyroid status to alter thyrotrope parameters. These data suggest an important interaction between the somatostatinergic system and thyroid hormone in the regulation of thyrotrope cell structure and function.
AuthorsW W Woodmansee, D F Gordon, J M Dowding, B Stolz, R V Lloyd, R A James, W M Wood, E C Ridgway
JournalThyroid : official journal of the American Thyroid Association (Thyroid) Vol. 10 Issue 7 Pg. 533-41 (Jul 2000) ISSN: 1050-7256 [Print] United States
PMID10958305 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.)
Chemical References
  • RNA, Messenger
  • Receptors, Somatostatin
  • somatostatin receptor 5
  • Thyrotropin
  • Thyroxine
  • Octreotide
Topics
  • Animals
  • Gene Expression
  • Mice
  • Octreotide (metabolism, pharmacology)
  • Pituitary Gland (chemistry, drug effects)
  • Pituitary Neoplasms (metabolism, pathology)
  • RNA, Messenger (analysis)
  • Receptors, Somatostatin (genetics, metabolism)
  • Reverse Transcriptase Polymerase Chain Reaction
  • Thyrotropin (analysis, biosynthesis, genetics)
  • Thyroxine (blood, pharmacology)
  • Tumor Cells, Cultured

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: